๐๐จ๐ฉ๐๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐๐๐๐ฌ ๐ฆ๐๐๐ก๐ข๐ง๐๐๐โ๐ฌ ๐
๐ฎ๐ง๐๐ข๐ง๐ ๐๐จ๐ฎ๐ง๐ ๐๐ง๐ ๐๐๐ซ๐ญ๐ง๐๐ซ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐๐๐ข๐ฎ๐ฌ๐๐ & ๐๐ฅ๐๐ฎ๐ค๐จ๐ฌ ๐จ๐ง ๐๐๐ฑ๐ญ-๐๐๐ง ๐๐ข๐ฌ๐ฎ๐๐ฅ ๐
๐ข๐๐ฅ๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ
โ ๐ ๐๐ฅ๐๐ฎ๐ค๐จ๐ฌ, ๐๐๐๐ข๐ฎ๐ฌ๐๐, ๐๐ง๐ ๐๐จ๐ฉ๐๐จ๐ง ๐๐๐ฎ๐ง๐๐ก ๐๐๐ฑ๐ญ-๐๐๐ง ๐๐ข๐ฌ๐ฎ๐๐ฅ ๐
๐ข๐๐ฅ๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ
RadiusXRยฎ, Topcon Healthcare, and Glaukos Corporation have collaborated to launch Inspireยฎ, a next-generation wearable vision testing platform. This innovative device integrates visual field testing with patient education and data-driven intelligence, aiming to enhance the diagnosis and management of ophthalmic diseases such as glaucoma. By combining RadiusXR's advanced technology, Topcon's expertise in robotic diagnostics, and Glaukos' commitment to expanding patient access, Inspireยฎ seeks to democratise eye care and improve outcomes worldwide.
๐ ๐๐จ๐ฉ๐๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐๐๐๐ฌ ๐ฆ๐๐๐ก๐ข๐ง๐๐๐โ๐ฌ ๐๐ซ๐-๐๐๐ซ๐ข๐๐ฌ ๐ ๐
๐ฎ๐ง๐๐ข๐ง๐ ๐๐จ๐ฎ๐ง๐
machineMD is excited to announce Topcon Healthcare as the lead investor in its pre-Series A funding round. By integrating machineMDโs technology with Topconโs Harmonyยฎ platform, the partnership aims to improve early detection of neurological diseases through ocular measurements.
@Dominic Senn, CEO of machineMD, shared, โTopcon Healthcare and machineMD share a bold ambition to shape the future of neurodiagnostics, making it more accessible, scalable, and data driven.โ This collaboration aims to advance predictive and personalized medicine, improving patient outcomes through earlier interventions globally.